[
  {
    "ts": null,
    "headline": "Top Research Reports for Boston Scientific, Union Pacific & Realty Income",
    "summary": "Boston Scientific gains from MedSurg and cardiovascular strength, while Union Pacific and Realty Income face mixed headwinds.",
    "url": "https://finnhub.io/api/news?id=49f73322b5db1a1f23e71a0bd7592d7bbff9e5518a7e16c99c899f1e4565417d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759439160,
      "headline": "Top Research Reports for Boston Scientific, Union Pacific & Realty Income",
      "id": 136960233,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DD",
      "source": "Yahoo",
      "summary": "Boston Scientific gains from MedSurg and cardiovascular strength, while Union Pacific and Realty Income face mixed headwinds.",
      "url": "https://finnhub.io/api/news?id=49f73322b5db1a1f23e71a0bd7592d7bbff9e5518a7e16c99c899f1e4565417d"
    }
  },
  {
    "ts": null,
    "headline": "JPMorgan says Corteva split announcement has not lowered company’s value",
    "summary": "Investing.com -- Corteva’s plan to split into two companies has drawn a negative initial market reaction, but JPMorgan sees an opportunity, upgrading the stock to Overweight.",
    "url": "https://finnhub.io/api/news?id=102bec3655549e2d3bf2ed38a42e450a77c64357413fe1b166091754e1f2ba3c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759419491,
      "headline": "JPMorgan says Corteva split announcement has not lowered company’s value",
      "id": 136960509,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DD",
      "source": "Yahoo",
      "summary": "Investing.com -- Corteva’s plan to split into two companies has drawn a negative initial market reaction, but JPMorgan sees an opportunity, upgrading the stock to Overweight.",
      "url": "https://finnhub.io/api/news?id=102bec3655549e2d3bf2ed38a42e450a77c64357413fe1b166091754e1f2ba3c"
    }
  },
  {
    "ts": null,
    "headline": "DuPont Announces 2025 Lavoisier Medal and Pedersen Award Recipients",
    "summary": "DuPont (NYSE:DD) today announced the recipients of the 2025 Lavoisier Medal for Lifetime Technical Achievement and the Pedersen Award.",
    "url": "https://finnhub.io/api/news?id=99ea5de3e83c77e157674742aad298f88d505705fb37ebe40b49e3b879667838",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759410000,
      "headline": "DuPont Announces 2025 Lavoisier Medal and Pedersen Award Recipients",
      "id": 136955655,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DD",
      "source": "Yahoo",
      "summary": "DuPont (NYSE:DD) today announced the recipients of the 2025 Lavoisier Medal for Lifetime Technical Achievement and the Pedersen Award.",
      "url": "https://finnhub.io/api/news?id=99ea5de3e83c77e157674742aad298f88d505705fb37ebe40b49e3b879667838"
    }
  },
  {
    "ts": null,
    "headline": "Chemours (CC) Price Target Lifted by Mizuho Amid Higher Market Multiples",
    "summary": "The Chemours Company (NYSE:CC) ranks among the best specialty chemicals stocks to invest in. Mizuho maintained its Outperform rating on The Chemours Company (NYSE:CC) and raised its price target from $16 to $19 on September 23. The increase is mostly attributable to higher market multiples, as Mizuho used a higher multiple of roughly 6.5x next-twelve-months […]",
    "url": "https://finnhub.io/api/news?id=1c4a58d7dfada7285d832865200f9b4b1078cc7c1cfbcb2f9bc10bbcc37e3b9d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759386820,
      "headline": "Chemours (CC) Price Target Lifted by Mizuho Amid Higher Market Multiples",
      "id": 136955605,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DD",
      "source": "Yahoo",
      "summary": "The Chemours Company (NYSE:CC) ranks among the best specialty chemicals stocks to invest in. Mizuho maintained its Outperform rating on The Chemours Company (NYSE:CC) and raised its price target from $16 to $19 on September 23. The increase is mostly attributable to higher market multiples, as Mizuho used a higher multiple of roughly 6.5x next-twelve-months […]",
      "url": "https://finnhub.io/api/news?id=1c4a58d7dfada7285d832865200f9b4b1078cc7c1cfbcb2f9bc10bbcc37e3b9d"
    }
  }
]